You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

insular thyroid cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Thyroid Carcinoma, Surgery Trial in Groningen (Bevacizumab-IRDye800CW)

Enrolling by invitation
  • Thyroid Carcinoma
  • Surgery
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 18, 2023

Thyroid Cancer, Thyroid, Refractory Thyroid Cancer Trial in New York (Surveillance Visit)

Recruiting
  • Thyroid Cancer
  • +2 more
  • Surveillance Visit
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 8, 2023

HRQOL in Locally Advanced Thyroid Carcinoma

Recruiting
  • Thyroid Cancer
  • +2 more
  • Tyrosine kinase inhibitor drugs.
  • Fuzhou, Fujian, China
    Road Fuma No.420
Apr 11, 2023

Oxidative Stress and Mitochondrial TERT in Papillary Thyroid

Recruiting
  • Papillary Thyroid Cancer
    • Milan, Italy
      Istituto Auxologico Italiano
    Mar 2, 2023

    Papillary Thyroid Cancer Trial in Baltimore (Radiofrequency Ablation)

    Active, not recruiting
    • Papillary Thyroid Cancer
    • Radiofrequency Ablation
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Dec 5, 2022

    Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

    Active, not recruiting
    • Thyroid Cancer
    • +2 more
    • Stanford, California
      Stanford University
    Nov 8, 2022

    Human Thyroid and Iodine Resistance

    Recruiting
    • Thyroid Cancer
    • Metabolites dosage
    • Toulouse, France
      Institut Claudius regaud IUCT Oncopole
    Dec 22, 2022

    Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

    Recruiting
    • Thyroid Cancer
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 19, 2023

    18F-TFB PET/CT Scan in Differentiated Thyroid Cancer

    Recruiting
    • Differentiated Thyroid Gland Carcinoma
    • +2 more
    • Computed Tomography
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Cross-sectional Case and Control Study on Quality of Life,

    Recruiting
    • Papillary Thyroid Carcinoma
    • Thyroid Cancer
    • Thyroid lobectomy via trans-axillary approach
    • Thyroid lobectomy via open approach
    • Beijing, Beijing, China
      Department of General Surgery, Peking Union Medical College Hosp
    Jul 5, 2023

    Role of Endocrine Disruptors in Thyroid Cancer

    Recruiting
    • Endocrine Disruptor Chemicals
    • Thyroid Cancer
    • Blood and urine diagnostic evaluation
    • Milan, Italy
      Istituto Auxologico Italiano, IRCCS
    Feb 28, 2023

    Tumor Deposits for Patients With Papillary Thyroid Carcinoma

    Completed
    • Exploring the Prognostic Value of Tumor Deposits PTC Patients
    • surgery
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Sep 18, 2023

    Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,

    Recruiting
    • Thyroid Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    Papillary Thyroid Carcinoma, Thermal Ablation Trial in Beijing (No Intervention)

    Recruiting
    • Papillary Thyroid Carcinoma
    • Thermal Ablation
    • No Intervention
    • Beijing, China
      Beijing Friendship Hospital
    Jul 19, 2023

    Efficacy of Lenvatinib in Differentiated Thyroid Cancer

    Recruiting
    • Differentiated Thyroid Cancer
    • Gender
    • Rome, Italy
      Regina Elena National Cancer Institute
    Mar 16, 2023

    Pathological Manifestation in Thyroid Follicular Neoplasm: Early

    Not yet recruiting
    • Thyroid Cancer
    • Follicular Thyroid Cancer
      • (no location specified)
      Jul 20, 2022

      Familial Non-medullary Thyroid Cancer

      Recruiting
      • Non-Medullary Thyroid Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Aug 24, 2022

        Metastic Thyroid Cancer Trial run by the NIDDK (68-Gallium-DOTATATE-PET/CT)

        Recruiting
        • Metastic Thyroid Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 28, 2023

        Thyroid Cancer, Lymph Node Trial in Leon (US-guided fine needle aspiration (FNA))

        Completed
        • Thyroid Cancer
        • Lymph Node
        • US-guided fine needle aspiration (FNA)
        • Leon, Guanajuato, Mexico
          Unidad Medica de Alta Especialidad No. 1, Bajío
        Nov 6, 2023

        Anaplastic Thyroid Cancer Trial in Japan (Lenvatinib, Nivolumab)

        Recruiting
        • Anaplastic Thyroid Cancer
        • Nagoya, Aichi, Japan
        • +9 more
        Jan 13, 2023

        Thyroid Cancer Trial in New York (Thyrotropin Releasing Hormone (TRH), levothyroxine, Hypothyroidism QOL questionnaire)

        Recruiting
        • Thyroid Cancer
        • Thyrotropin Releasing Hormone (TRH)
        • +2 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Aug 12, 2022

        Reminder System (TCARS) Study - A Pilot Study.

        Not yet recruiting
        • Low Risk Differentiated Thyroid Cancer
        • Shared-care model
        • (no location specified)
        Aug 18, 2022

        Differentiated Thyroid Cancer Trial in China (AL2846 capsule)

        Recruiting
        • Differentiated Thyroid Cancer
        • AL2846 capsule
        • Guilin, Guangxi, China
        • +3 more
        Feb 27, 2023